Domestic private health expenditure in Europe & Central Asia
Europe & Central Asia: Domestic private health expenditure was 26.6% in 2023. ▬ Flat
Domestic private health expenditure in Europe & Central Asia, 2000–2023
Source: Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO). Measured in % of current health expenditure.
Analysis
Europe & Central Asia recorded 26.6% for domestic private health expenditure in 2023.
The figure is up 6.1% on the previous year and down 3.6% over ten years.
Over the whole period, domestic private health expenditure in Europe & Central Asia peaked at 27.6% in 2013 and was at its lowest, 24.4%, in 2020.
That places Europe & Central Asia 42nd out of 47 groups with data for 2023, putting it in the bottom quarter.
Domestic private health expenditure in Europe & Central Asia, year by year
| Year | % of current health expenditure | Change |
|---|---|---|
| 2000 | 27.0% | — |
| 2001 | 26.8% | -0.7% |
| 2002 | 26.6% | -0.8% |
| 2003 | 26.5% | -0.5% |
| 2004 | 26.6% | +0.5% |
| 2005 | 26.4% | -0.9% |
| 2006 | 26.6% | +0.9% |
| 2007 | 27.0% | +1.2% |
| 2008 | 26.8% | -0.6% |
| 2009 | 26.3% | -2.0% |
| 2010 | 26.7% | +1.5% |
| 2011 | 27.1% | +1.8% |
| 2012 | 27.5% | +1.2% |
| 2013 | 27.6% | +0.5% |
| 2014 | 27.5% | -0.3% |
| 2015 | 27.5% | -0.1% |
| 2016 | 27.0% | -1.8% |
| 2017 | 27.2% | +0.8% |
| 2018 | 27.0% | -0.7% |
| 2019 | 27.1% | +0.4% |
| 2020 | 24.4% | -10.1% |
| 2021 | 24.6% | +1.1% |
| 2022 | 25.1% | +1.8% |
| 2023 | 26.6% | +6.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 26.7% | 26.3% | 27.0% | 10 |
| 2010s | 27.2% | 26.7% | 27.6% | 10 |
| 2020s | 25.2% | 24.4% | 26.6% | 4 |
Countries ranked near Europe & Central Asia
More health data for Europe & Central Asia
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0339 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0299 units per person (2025)
- Population ages 45-49, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0346 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, male, annual growth rate 0.6344 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
Frequently asked questions
- What is domestic private health expenditure in Europe & Central Asia?
- Domestic private health expenditure in Europe & Central Asia was 26.6% in 2023, according to Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO).
- What is the highest domestic private health expenditure recorded in Europe & Central Asia?
- The highest recorded value was 27.6% in 2013.
- What is the lowest domestic private health expenditure recorded in Europe & Central Asia?
- The lowest recorded value was 24.4% in 2020.
- How does Europe & Central Asia rank for domestic private health expenditure?
- Europe & Central Asia ranks 42nd out of 47 groups with data for 2023.
- Is domestic private health expenditure rising or falling in Europe & Central Asia?
- Over the last ten years it is down 3.6%. The long-run trend across the full record is flat.
- Where does this Europe & Central Asia data come from?
- The figures come from Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as part of Domestic private health expenditure (% of current health expenditure). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Share of current health expenditures funded from domestic private sources. Domestic private sources include funds from households, corporations and non-profit organizations. Such expenditures can be either prepaid to voluntary health insurance or paid directly to healthcare providers.